myelodysplastic syndromes/seizures

Veza se sprema u međuspremnik

Odaberite vrstu sortiranja

Page 1 od 24 rezultati

The use of r-HuEpo in the treatment of anaemia related to myelodysplasia (MDS).

Samo registrirani korisnici mogu prevoditi članke

Prijavite se / prijavite se

One hundred and sixteen (116) anaemic patients with myelodysplastic syndromes (MDS) were treated with recombinant human erythropoietin (r-HuEpo) in an open-label, multicentre, compassionate treatment trial; 100 patients received therapy for > or = 4 weeks and were evaluable for efficacy. The

A case of posterior reversible encephalopathy syndrome in a child with myelodysplastic syndrome following allogenic bone marrow transplantation.

Samo registrirani korisnici mogu prevoditi članke

Prijavite se / prijavite se

Posterior reversible encephalopathy syndrome (PRES) is an uncommon but distinctive clinical-radiologic entity characterized by headache, seizures, visual disturbance, and altered mental function associated with reversible white matter edema affecting the posterior parietal and occipital lobes of the

Myelodysplastic syndrome associated with chronic valproic acid therapy: a case report and review of the literature.

Samo registrirani korisnici mogu prevoditi članke

Prijavite se / prijavite se

This report is of a case of myelodysplastic syndrome occurring in a 63 year old female on long-term valproic acid therapy for seizure disorder. Valproic acid therapy is widely prescribed for seizure disorders and is often associated with thrombocytopenia, macrocytic anemia and a reversible

Rapidly progressive toxic leukoencephalomyelopathy with myelodysplastic syndrome: a clinicopathological correlation.

Samo registrirani korisnici mogu prevoditi članke

Prijavite se / prijavite se

Neurological disorders induced by long-term exposure to organic solvents typically have a slowly progressive clinical course, which may be arrested or even reversed following discontinuation of exposure. We report an unusual case of rapidly progressive toxic leukoencephalomyelopathy in a 29-year-old

Antithymocyte globulin has limited efficacy and substantial toxicity in unselected anemic patients with myelodysplastic syndrome.

Samo registrirani korisnici mogu prevoditi članke

Prijavite se / prijavite se

Antithymocyte globulin (ATG) has recently been popularized as an effective treatment in myelodysplastic syndrome (MDS). We treated 8 anemic MDS patients (refractory anemia [RA] and refractory anemia with excess blasts [RAEB-1]) with ATG (40 mg/kg/d for 4 days) and prednisone in a phase 2 trial. The

Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy.

Samo registrirani korisnici mogu prevoditi članke

Prijavite se / prijavite se

We analysed the clinical features, course and response to immunosuppressive therapy in 30 patients with autoimmune disorders associated with myelodysplastic syndromes (MDS). 18 patients with MDS developed acute systemic autoimmune disorders. Common manifestations were skin vasculitis (n = 15) and

Cortical blindness and seizures in a patient receiving FK506 after bone marrow transplantation.

Samo registrirani korisnici mogu prevoditi članke

Prijavite se / prijavite se

A 54-year-old woman with a myelodysplastic syndrome treated with high-dose chemotherapy and an allogenic bone marrow transplant developed acute cortical blindness while receiving tacrolimus (FK506). MRI showed white matter abnormalities. After discontinuation of FK506, the patient's vision returned

Bone marrow transplantation in Shwachman-Diamond syndrome: report of two cases and review of the literature.

Samo registrirani korisnici mogu prevoditi članke

Prijavite se / prijavite se

Patients with Shwachman-Diamond syndrome (SDS) have an increased frequency of myelodysplasia and leukemic transformation. We described two patients who received allogeneic stem cell transplantation and developed multiple complications, including seizure, hyperglycemia and renal tubular acidosis. A

Neuropsychiatric disturbances in a patient with a nonmosaic isodicentric (X) (q21.32) chromosome.

Samo registrirani korisnici mogu prevoditi članke

Prijavite se / prijavite se

A 41-year-old female patient with mental retardation and generalized epileptic seizure had a nonmosaic idic (X) (pter-q21.32::q21.32-pter) chromosome in peripheral lymphocytes and bone marrow cells. Primary amenorrhea, myelodysplastic syndrome, pigmented nevi and characteristic facial appearance

Successful electroconvulsive therapy in an elderly man with severe thrombocytopenia: case report and literature review.

Samo registrirani korisnici mogu prevoditi članke

Prijavite se / prijavite se

Electroconvulsive therapy (ECT) is a safe and effective treatment for depression. Furthermore, modifications to ECT have made it a safe procedure for patients who were previously thought to be too ill or old to undergo the stress of convulsions. Little is known, however, of the safety of performing

Neurogenic bladder dysfunction as a signal of late failure of endoscopic third ventriculostomy in a child with spina bifida.

Samo registrirani korisnici mogu prevoditi članke

Prijavite se / prijavite se

Endoscopic third ventriculostomy (ETV) is an option for hydrocephalus treatment in patients with Myelomeningocele mostly after a previous shunt dysfunction. Late failure of ETV is a rare event and it is traditionally associated with dramatic symptoms of intracranial hypertension. In

Severe hematologic toxicity of valproic acid. A report of four patients.

Samo registrirani korisnici mogu prevoditi članke

Prijavite se / prijavite se

Four patients with severe cerebral palsy, mental retardation, and seizures who were treated with valproic acid showed a broad spectrum of hematologic toxicity, which included thrombocytopenia, macrocytic red cells with or without anemia, and the Pelger-Huet anomaly in the segmented neutrophils,

Treatment of acute leukemia in relapse with 4'(9-acridinylamino) methanesulfon-m-anisidide (AMSA) in combination with cytosine arabinoside and thioguanine.

Samo registrirani korisnici mogu prevoditi članke

Prijavite se / prijavite se

Thirty-seven patients with acute leukemia in relapse were treated with a three-drug combination that included a 3- or 4-day course of AMSA with total doses ranging from 600 mg/m2 to 740 mg/m2 I.V., cytosine arabinoside 25 mg/m2 I.V. followed by 200 mg/m2 by continuous infusion daily for 5 days, and

Clinical reasoning: A 68-year-old man with a first presentation of status epilepticus.

Samo registrirani korisnici mogu prevoditi članke

Prijavite se / prijavite se

A 64-year-old man with transfusion-dependent myelodysplastic syndrome (MDS), hypertension, chronic obstructive pulmonary disease, hypothyroidism, blindness from treated syphilitic chorioretinitis, and no prior seizure history presented in generalized status epilepticus. His daily home medication

Meropenem -valproic acid interaction in patients with cefepime-associated status epilepticus.

Samo registrirani korisnici mogu prevoditi članke

Prijavite se / prijavite se

OBJECTIVE Two case reports of rapid decreases in valproic acid levels after initiation of meropenem in patients who developed new-onset seizure activity during treatment with cefepime are presented. CONCLUSIONS A 60-year-old Caucasian woman with myelodysplasia was transferred to the medical

Prethodni
1
2
Sljedeći

Pridružite se našoj
facebook stranici

Herbal & Natural Medicine

Najkompletnija baza ljekovitog bilja potpomognuta naukom

Radi na 55 jezika
Biljni lijekovi potpomognuti naukom
Prepoznavanje biljaka po slici
Interaktivna GPS karta - označite bilje na lokaciji (uskoro)
Pročitajte naučne publikacije povezane sa vašom pretragom
Pretražite ljekovito bilje po učincima
Organizirajte svoja interesovanja i budite u toku sa istraživanjem vijesti, kliničkim ispitivanjima i patentima

Upišite simptom ili bolest i pročitajte o biljkama koje bi mogle pomoći, unesite travu i pogledajte bolesti i simptome protiv kojih se koristi.
* Sve informacije temelje se na objavljenim naučnim istraživanjima